.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B06A_OtherHematologicalAgents.B06AX04_Mitapivat.Mitapivat

Information

name:Mitapivat
ATC code:B06AX04
route:oral
n-compartments2

Mitapivat is a first-in-class, oral pyruvate kinase activator used in the treatment of hemolytic anemia in adults with pyruvate kinase deficiency. It is an approved drug, notably by the FDA and EMA.

Pharmacokinetics

Pharmacokinetic parameters observed following single and multiple oral doses in healthy adult volunteers, both male and female.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos